Clinical Trial Update: Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters [Phase 3]

View source ↗

Summary

Phase 3 trial investigating rivaroxaban versus vitamin K antagonists for anticoagulation after vena cava filter implantation; recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Rivaroxaban (rivaroxaban)
• Vitamin K antagonists

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Venous Thromboembolism | Phase 3 | Status: RECRUITING